These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 3056742)
1. [Pharmacological aspects of the problem of leukotrienes]. Luĭk AI; Lipkan GN Farmakol Toksikol; 1988; 51(4):104-9. PubMed ID: 3056742 [TBL] [Abstract][Full Text] [Related]
2. [The physiological role and pharmacological correction of the effects of prostanoids and leukotrienes]. Chernov IuN; Batishcheva GA; Vasin MV Farmakol Toksikol; 1990; 53(6):64-71. PubMed ID: 2081573 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacologic interactions and the therapeutic implications of leukotrienes (II)]. Nechifor M Rev Med Chir Soc Med Nat Iasi; 1988; 92(2):232, 251-2. PubMed ID: 3187228 [No Abstract] [Full Text] [Related]
5. Pharmacology of peptide leukotriene receptor antagonists. Aharony D; Krell RD Ann N Y Acad Sci; 1991; 629():125-32. PubMed ID: 1952544 [No Abstract] [Full Text] [Related]
6. [The medical implications of leukotrienes. III]. Nechifor M Rev Med Chir Soc Med Nat Iasi; 1988; 92(3):601-3. PubMed ID: 3074442 [No Abstract] [Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
8. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle. Jonsson EW Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121 [TBL] [Abstract][Full Text] [Related]
9. Leukotrienes: lipid bioeffectors of inflammatory reactions. Sala A; Zarini S; Bolla M Biochemistry (Mosc); 1998 Jan; 63(1):84-92. PubMed ID: 9526099 [TBL] [Abstract][Full Text] [Related]
10. Neurally mediated actions of leukotrienes on ion transport in guinea pig distal colon. Hammerbeck DM; Brown DR J Pharmacol Exp Ther; 1993 Jan; 264(1):384-90. PubMed ID: 8093730 [TBL] [Abstract][Full Text] [Related]
11. Formation and effects of leukotrienes and lipoxins in human bone marrow. Lindgren JA; Stenke L; Mansour M; Edenius C; Laurén L; Näsman-Glaser B; Ericsson I; Reizenstein P J Lipid Mediat; 1993; 6(1-3):313-20. PubMed ID: 8357990 [TBL] [Abstract][Full Text] [Related]
12. [Physiopathology of asthma: what role for leukotrienes?]. Lockhart A; Dinh-Xuan AT Rev Pneumol Clin; 1997; 53(3):119-27. PubMed ID: 9296112 [TBL] [Abstract][Full Text] [Related]
14. Leukotrienes mediate 5-hydroxytryptamine-induced plasma extravasation in the rat knee joint via CysLT-type receptors. Wang Y; Mitchell J; Sharma M; Gabriel A; Moriyama K; Palmer PP Inflamm Res; 2004 Feb; 53(2):66-71. PubMed ID: 15021971 [TBL] [Abstract][Full Text] [Related]
15. Summary: the pharmacology of leukotrienes in asthma. Costello J; Meltzer S; Bleecker ER Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():263-8. PubMed ID: 7771340 [No Abstract] [Full Text] [Related]
16. Leukotrienes and atherosclerosis: new roles for old mediators. Jala VR; Haribabu B Trends Immunol; 2004 Jun; 25(6):315-22. PubMed ID: 15145321 [TBL] [Abstract][Full Text] [Related]
17. [In vitro study of of the effects of cysteinyl leukotrienes on human vascular preparations]. Stanke-Labesque F; Cracowski JL; Devillier P; Bessard G Therapie; 2000; 55(1):29-33. PubMed ID: 10859998 [TBL] [Abstract][Full Text] [Related]
18. Leukotriene modifiers in the treatment of cardiovascular diseases. Riccioni G; Capra V; D'Orazio N; Bucciarelli T; Bazzano LA J Leukoc Biol; 2008 Dec; 84(6):1374-8. PubMed ID: 18794213 [TBL] [Abstract][Full Text] [Related]
20. The subiculum: a potential site of action for novel antipsychotic drugs? Greene JR Mol Psychiatry; 1996 Nov; 1(5):380-7. PubMed ID: 9154231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]